HomeProductsBuilding BlocksHeterocyclic ScaffoldsThiazolesLusutrombopag
Chemical structure of CAS 1110766-97-6

Lusutrombopag

CAS No.1110766-97-6
MDL No.MFCD28502075
MFC29H32Cl2N2O5S
MW591.50
InChI KeyNOZIJMHMKORZBA-KJCUYJGMSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Lusutrombopag belongs to the cinnamic acid class.

CAS No.1110766-97-6
Product NameLusutrombopag

Biological Targets

MPL

Associated Conditions

Thrombocytopenia·autoimmune thrombocytopenic purpura·hemorrhage
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Lusutrombopag as a Repurposing Drug in Combination with Aminoglycosides against Vancomycin-Resistant Enterococcus.

ACS infectious diseases • Vol. 10, Issue 4 • 2024
PMID: 38567846DOI: 10.1021/acsinfecdis.3c00737

Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl.

Experimental hematology • Vol. 59 • 2018
PMID: 29274361DOI: 10.1016/j.exphem.2017.12.005

Efficacy of Repeated Lusutrombopag Administration for Thrombocytopenia in a Patient Scheduled for Invasive Hepatocellular Carcinoma Treatment.

Internal medicine (Tokyo, Japan) • Vol. 56, Issue 21 • 2017
PMID: 28943563PMC: PMC5709632DOI: 10.2169/internalmedicine.8791-16

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient.

Clinical journal of gastroenterology • Vol. 10, Issue 3 • 2017
PMID: 28324272PMC: PMC5429890DOI: 10.1007/s12328-017-0735-2

Documentation